|
CDK17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.064800E-03 |
| Normal-vs-Stage3 |
9.33310000394982E-08 |
| Normal-vs-Stage4 |
1.98689999997281E-06 |
| Stage1-vs-Stage2 |
3.624800E-01 |
| Stage1-vs-Stage3 |
3.482400E-02 |
| Stage1-vs-Stage4 |
3.065500E-02 |
| Stage2-vs-Stage3 |
7.711400E-01 |
| Stage2-vs-Stage4 |
7.221800E-01 |
| Stage3-vs-Stage4 |
9.069800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-16 |
| Normal-vs-AfricanAmerican |
4.637400E-04 |
| Normal-vs-Asian |
5.648000E-02 |
| Caucasian-vs-AfricanAmerican |
4.595600E-01 |
| Caucasian-vs-Asian |
7.396600E-01 |
| AfricanAmerican-vs-Asian |
5.681800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.19568807580117E-12 |
| Normal-vs-Female |
6.82787160144471E-14 |
| Male-vs-Female |
2.299000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.536900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.7537082896979E-12 |
| Normal-vs-Age(61-80Yrs) |
3.45123929434976E-12 |
| Normal-vs-Age(81-100Yrs) |
3.672100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.423400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.937200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.563200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.807420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.387700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.124400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.358120E-03 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
2.60739996260639E-09 |
| Normal-vs-Grade 4 |
4.608700E-04 |
| Grade 1-vs-Grade 2 |
2.868000E-01 |
| Grade 1-vs-Grade 3 |
3.085700E-02 |
| Grade 1-vs-Grade 4 |
5.041600E-03 |
| Grade 2-vs-Grade 3 |
3.58089999999978E-05 |
| Grade 2-vs-Grade 4 |
8.232200E-04 |
| Grade 3-vs-Grade 4 |
6.636000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
2.52700000036299E-07 |
| ccA subtype-vs-ccB subtype |
9.69180000000014E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.73674441284311E-12 |
| Normal-vs-N1 |
1.527950E-01 |
| N0-vs-N1 |
1.978000E-01 |
|
|
